Dezhan Healthcare Company Limited

Equities

000813

CNE000000VV8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
2.7 CNY -1.10% Intraday chart for Dezhan Healthcare Company Limited -4.26% -17.43%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Dezhan Healthcare Company Limited completed the acquisition of additional 18% stake in Shanghai Deyi Pharmaceutical Co., Ltd. from Hanyi Biotechnology Co., Ltd. CI
Dezhan Healthcare to Boost Stake in Deyi Pharmaceutical for 37.8 Million Yuan; Shares Slump 8% MT
Dezhan Healthcare Company Limited agreed to acquire additional 18% stake in Shanghai Deyi Pharmaceutical Co., Ltd. from Hanyi Biotechnology Co., Ltd. for CMY 37.8 million. CI
Dezhan Healthcare Company Limited(XSEC:000813) added to S&P Global BMI Index CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Dezhan HealthCare Chairman Resigns MT
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022. CI
Equity Buyback announced on September 7, 2022 has expired with 52,913,582 shares, representing 2.33% for CNY 180.26 million. CI
Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022. CI
Dezhan HealthCare Earmarks 489 Million Yuan on Medical Health Complex Project MT
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022. CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022. CI
Dezhan HealthCare Settles Litigation With Former Investment Partner MT
Dezhan Healthcare Company Limited commences an Equity Buyback Plan for CNY 345 million, under the authorization approved on May 26, 2022. CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Dezhan Healthcare Company Limited Announces Executive Appointments CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chart Dezhan Healthcare Company Limited
More charts
Dezhan HealthCare Co Ltd, formerly Xinjiang Tianshan Wool Tex Stock Co Ltd, is a China-based company mainly engaged in the research and development, production and sales of pharmaceuticals. The Company focuses on cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, ecological water and other fields. Its subsidiaries optimize the structure of combined products, introduce production lines that meet the production needs of multiple dosage forms according to product development needs, and increase products such as injections, biopharmaceuticals, and Chinese medicine preparations. The Company mainly conducts its businesses in the China market.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 000813 Stock
  4. News Dezhan Healthcare Company Limited
  5. Dezhan HealthCare Earmarks 489 Million Yuan on Medical Health Complex Project